InvestorsObserver
×
News Home

Analyst Rating: Will InspireMD Inc (NSPR) Stock Outperform the Market?

Friday, February 12, 2021 03:21 PM | InvestorsObserver Analysts

Mentioned in this article

Analyst Rating: Will InspireMD Inc (NSPR) Stock Outperform the Market?

InvestorsObserver is giving InspireMD Inc (NSPR) an Analyst Rating Rank of 78, meaning NSPR is ranked higher by analysts than 78% of stocks. The average price target for NSPR is $0.85 and analyst’s rate the stock as a Strong Buy

Overall Score - 5
Wall Street analysts are rating NSPR a Strong Buy today. Find out what this means to you and get the rest of the rankings on NSPR!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.

InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With InspireMD Inc Stock Today?

InspireMD Inc (NSPR) stock is lower by -6.49% while the S&P 500 has risen 0.08% as of 3:13 PM on Friday, Feb 12. NSPR is lower by -$0.08 from the previous closing price of $1.31 on volume of 12,800,174 shares. Over the past year the S&P 500 is higher by 16.17% while NSPR has risen 10.81%. NSPR lost -$1.26 per share the over the last 12 months.

Click Here to get the full report on InspireMD Inc (NSPR) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App